– Study is the Company’s first trial evaluating ability of M2SR and the current licensed standard of care to protect against drifted virus strains, and its second study in older… read more →
Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice a b s t r a c t Both influenza A and B viruses cause outbreaks… read more →
VIRUS PROTECTION | EUROPEAN STUDY PLANNED JUDY NEWMAN jdnewman@madison.com FluGen, a Madison company developing a universal influenza vaccine, is gearing up for a new round of studies on human volunteers… read more →
FluGen-Arecor Partnership Enhances Promise of Universal Flu Vaccine Through Funding Award from the UK’s innovation agency, the Technology Strategy Board Cambridge, UK – Arecor Ltd of Cambridge, England received the “green… read more →
UW-Madison virologist part of international research team studying virus By Karen Herzog of the Journal Sentinel. Original article here. A new bird flu virus responsible for at least 37 deaths in China since… read more →